When Prof. James Brenton was seeing one of his patients at Addenbrooke’s Hospital recently for ovarian cancer treatment, he needed to review all her studies and treatments. The information was complex and lengthy: blood test results, genomic tests, imaging studies and reports from past therapy. Brenton hadn’t been able to attend the tumor board meeting the day before, where his colleagues — radiation oncologists, medical oncologists, radiologists, pathologists and surgeons — had reviewed her data. The recap from the meeting was helpful, but overly brief.
×
GE.com has been updated to serve our three go-forward companies.
Please visit these standalone sites for more information